Intelligent drug and/or fluid delivery system to optimizing medical treatment or therapy using pharmacodynamic and/or pharamacokinetic data

Patent metadata

Field	Value
Publication number	US-9950112-B2
Application number	US-201113817165-A
Country	US
Kind code	B2
Filing date	Aug 17, 2011
Priority date	Aug 17, 2010
Publication date	Apr 24, 2018
Grant date	Apr 24, 2018

Abstract

A pharmacodynamic (PD), pharmacokinetic (PK), or both and PK guided infusion device, system and method optimizes the safety and efficacy of various forms of treatment or therapy (e.g., drug and/or fluid) in a variety of health-care and other settings.

First claim

What is claimed is:

1. A medication delivery control system comprising:
(a) an apparatus comprising at least one photoplethysmography (PPG) sensor that obtains a PPG signal from a site at a subject's nose;
(b) an infusion device that provides medication to the subject's nose;
(c) a controller for receiving PPG signals from the PPG sensor and, based on the signals, increasing, decreasing or maintaining a rate of infusion of the infusion device, and
(d) an accelerometer or other motion sensing device
wherein the system is in a sleep mode wherein power consumption is reduced until the controller determines that the subject is sleeping or in state of respiratory depression based on signals from the accelerometer or other motion sensing device; and
wherein the medication delivery control system is a wearable device adapted to be secured to the nose and/or head of the subject.

2. The medication delivery control system according to claim 1 , wherein the PPG signals are obtained from the subject's nasal alar.

3. The medication delivery control system according to claim 1 , further comprising a nasal pressure or flow sensor, and optionally, an ECG electrode.

4. The medication delivery control system according to claim 1 , further comprising an intranasal tube that is adapted to be emplaced inside the subject's nostril and delivers pre-metered doses of medications.

5. The medication delivery control system according to claim 4 , wherein the system delivers nitric oxide, histamine, or methacholine to nasal mucosa, either as part of the medications or as a separate feed.

6. The medication delivery control system of claim 4 , wherein the medications comprise at least one of opioids, opioid antagonists, vasoactive drugs, steroids, dissociative agents and anxiolytics.

7. The medication delivery control system of claim 4 , wherein the system delivers medications through the nasal epithelium.

8. The medication delivery control system of claim 1 , further comprising at least one PPG sensor adapted to be secured to a peripheral site of the subject.

9. The medication delivery control system of claim 1 , wherein the system:
(i) obtains measurements of at least one of the subject's vital signs selected from the group consisting of nasal pressure/flow, electrocardiographic signals, blood pressure, heart rate, heart rate variability, arrhythmias, respiratory rate, respiratory effort indicative of work of breathing, inspiratory and expiratory breathing ratios (I:E ratios), patterns of indicative of normal respiration or respiratory depression, plethysmography signals, blood oxygen saturation, blood volume, including local arterial blood flow amplitude, venous capacitance and comparative flows and capacitance from two or more site indicative of hypovolemia/shock and/or loss of extremity perfusion, pulse transit time, pulse wave velocity and combinations thereof,
(ii) processes the measurements to determine a relative state of health and, based on the determination,
(iii) infuses at least one medication to the subject based on the determination in (ii).

10. The medication delivery control system of claim 1 , wherein the system is operated by remote personnel.

11. The medication delivery control system of claim 1 , wherein the system is part of a helmet, telemetry or communications gear.

12. The medication delivery control system of claim 9 , wherein the system wirelessly communicates vital sign information to remote personnel.

Assignees

• Melker Richard J
• Dennis Donn M
• Melker Jeremy
• Rice Mark
• Hurley Robert
• Univ Florida
• Xhale Inc

Inventors

• Melker Richard J
• Dennis Donn M
• Melker Jeremy
• Rice Mark
• Hurley Robert

Classifications

• A61B5/1455

  using optical sensors, e.g. spectral photometrical oximeters · CPC title

• A61B5/0205

  Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition · CPC title

• A61B5/036

  by means introduced into body tracts (A61B5/032 and A61B5/035 take precedence) · CPC title

• A61M5/31511

  Piston or piston-rod constructions, e.g. connection of piston with piston-rod (A61M5/5066 takes precedence) · CPC title

• A61M5/168

  Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters {; Monitoring media flow to the body (flow control in general G05D7/00)} · CPC title